Mega Lifesciences Public Company Limited

Mega Lifesciences Public Company Limited

MEGA · BK · Healthcare / Drug Manufacturers - Specialty & Generic

36.75THB+1.50 (+4.26%)

Price History

Full chart

Market Stats

Previous Close35.25
Open36.00
Day Range36.00 – 37.00
52-Week Range26.51 – 38.84
Volume2.07M
Market Cap29.43B
P/E (TTM)13.45
Forward P/E13.09
EPS2.51
Dividend Yield5.04%
Beta0.30
50-Day Avg36.52
200-Day Avg35.82

About

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. The company operates through three segments: Brands, Distribution, and Original Equipment Manufacture. It offers wellness and nutrition products, including medical and sports nutrition, general well-being, vitamins, probiotics, herbal medicines, and cough and cold medicines, as well as hair, kid's, men's, and women's care products; and various health concerns products, such as allergy, bone and joint, gut, liver, diabetic, eye, heart, brain, sleep and anxiety, pain, and skin care, as well as blood circulation and memory. The company also provides prescription medicines for anti-allergic, anti-infective, cardiovascular system, central nervous system, dermatology, diabetes, gastrointestinal, gynecology, nephrology, oncology, ophthalmology, orthopedic, pain, respiratory, rheumatology, and urology areas under the MEGA We care brand name. In addition, it offers logistical and marketing services for trading and sale of goods manufactured by third parties comprising warehouse management, collections, and value-added services; natural and plant-based health foods; digital support solutions; and operation of wellness center. Further, the company is involved in social enterprise; and software design, development, and other services. It sells its products in in Southeast Asia, Sub-Saharan Africa, Australia, Europe, and South America. Mega Lifesciences Public Company Limited was incorporated in 1982 and is headquartered in Bangkok, Thailand.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Vivek Dhawan
  • Employees0
  • Headquarters909, Ample Tower, Bangkok, Thailand, 10260, Thailand
  • Websitehttps://www.megawecare.com

Leadership

  • Mr. Vivek DhawanCEO, Head of ESG, Chief Coach & Executive Director · b. 1961
  • Mr. Thomas AbrahamCFO, Head Coach & Executive Director · b. 1963
  • Mr. Deepak PanjwaniChief Risk & Compliance Officer · b. 1974
  • Mr. Paramjit Singh SawhneyPresident of International & Head Coach · b. 1963
  • Mr. Girish WadhwaPresident of Myanmar & Head Coach · b. 1970
  • Ms. Duangnapa TongsiriPresident of Mega We Care Thailand & Head Coach · b. 1960
  • Ms. Sujintana BoonworapatCorporate Secretary · b. 1972
  • Mr. Manoj GurbuxaniDeputy Chief Financial Officer · b. 1974
  • Francis RegoRegional Finance Head at Mega LifeSciences Pty. Ltd.

Financials

Income Statement

Currency: THB2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.86B5.96B7.03B7.73B7.94B8.81B9.60B10.34B11.13B12.59B14.14B15.69B15.68B15.34B14.15B
Growth (%)-+22.81%+17.92%+9.90%+2.78%+10.89%+8.93%+7.75%+7.62%+13.11%+12.28%+10.97%-0.03%-2.15%-7.80%
Cost of Revenue2.55B3.33B4.07B4.61B4.54B5.12B5.28B5.75B6.55B7.60B8.22B8.65B8.70B7.59B6.88B
Gross Profit2.31B2.63B2.96B3.12B3.41B3.69B4.32B4.59B4.58B4.99B5.91B7.04B6.98B7.75B7.27B
Gross Margin47.54%44.15%42.08%40.32%42.88%41.85%45.02%44.39%41.14%39.61%41.81%44.88%44.51%50.54%51.37%
Operating Expense1.72B1.92B2.21B2.46B2.70B2.66B2.94B3.15B3.15B3.32B3.73B4.32B4.07B4.38B4.36B
Operating Income589.59M711.18M746.82M654.26M710.52M1.03B1.38B1.45B1.43B1.67B2.18B2.72B2.90B3.37B2.90B
Operating Margin12.14%11.92%10.62%8.46%8.94%11.69%14.38%13.98%12.82%13.23%15.40%17.35%18.52%21.96%20.52%
EBITDA657.35M798.28M845.70M785.69M985.77M1.11B1.48B1.59B1.53B2.00B2.58B2.90B2.58B2.67B2.74B
EBITDA Margin13.53%13.38%12.02%10.16%12.41%12.56%15.41%15.42%13.77%15.86%18.26%18.46%16.44%17.43%19.39%
Net Income455.89M555.60M624.02M547.88M695.75M794.91M1.11B1.21B1.14B1.39B1.95B2.24B1.99B2.01B1.91B
Net Income Margin9.39%9.31%8.87%7.09%8.76%9.02%11.59%11.66%10.23%11.06%13.77%14.29%12.71%13.12%13.51%
R&D6.66M9.57M15.48M24.60M29.11M32.69M29.91M29.21M27.16M27.37M40.52M44.40M41.31M44.05M56.29M
R&D as % of Total Revenue0.14%0.16%0.22%0.32%0.37%0.37%0.31%0.28%0.24%0.22%0.29%0.28%0.26%0.29%0.40%
Interest Expense22.90M25.08M28.23M17.13M12.54M22.24M25.80M33.98M65.15M72.28M28.27M28.73M31.25M38.49M55.08M
Interest Expense % of Total Revenue0.47%0.42%0.40%0.22%0.16%0.25%0.27%0.33%0.59%0.57%0.20%0.18%0.20%0.25%0.39%

Balance Sheet

Currency: THB2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.22B3.29B4.14B6.54B6.72B7.61B7.94B8.72B9.63B10.53B11.59B13.27B14.65B14.52B14.21B16.00B
Total Liabilities1.37B1.97B2.51B2.84B2.74B3.28B3.26B3.48B3.91B4.36B4.61B5.25B5.87B5.22B4.33B5.78B
Total Equity830.75M1.30B1.60B3.69B3.98B4.33B4.68B5.24B5.72B6.17B6.96B8.00B8.78B9.30B9.88B10.22B
Cash100.75M329.97M353.79M1.54B340.63M515.68M565.86M477.67M559.53M1.25B1.01B2.20B2.45B2.36B3.46B4.29B
Total Debt565.98M737.96M1.20B996.92M567.14M718.51M669.71M512.17M959.82M890.48M647.47M356.33M420.87M251.84M491.24M683.54M
Net Debt465.24M407.99M844.53M-543.38M226.50M202.83M103.85M34.50M400.29M-357.45M-358.98M-1.84B-2.03B-2.10B-2.97B-3.60B

Cash Flow

Currency: THB2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow266.67M342.02M465.77M614.22M609.12M1.26B927.00M919.36M1.50B1.63B2.73B2.00B1.93B2.40B2.81B
Investing Cash Flow-76.92M-625.57M-396.25M-1.14B-184.27M-716.97M-352.54M-647.22M-172.47M-650.28M-264.68M-280.82M-250.01M1.45M-669.11M
Financing Cash Flow39.47M303.62M1.10B-671.41M-246.70M-473.09M-624.93M-176.96M-621.31M-1.22B-1.31B-1.43B-1.68B-1.28B-1.25B
Capital Expenditure80.01M629.56M401.97M218.67M193.22M298.39M227.85M751.90M540.82M255.07M159.78M312.74M274.65M257.29M663.89M
Free Cash Flow186.66M-287.54M63.80M395.55M415.90M962.06M699.15M167.46M954.29M1.37B2.57B1.68B1.63B2.14B2.14B
Dividends Paid93.89M144.85M846.19M242.55M353.58M407.41M467.31M614.50M618.10M670.19M922.94M1.41B1.44B1.39B1.39B
FCF to OCF70.00%-84.07%13.70%64.40%68.28%76.33%75.42%18.21%63.83%84.35%94.14%84.34%84.76%89.29%76.35%
Dividend Paid to FCF50.30%-50.38%1326.31%61.32%85.01%42.35%66.84%366.95%64.77%48.76%35.95%83.47%88.14%65.04%65.09%

Earnings

Report DateNov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Nov 13, 2014Feb 24, 2015May 12, 2015Aug 13, 2015Nov 12, 2015Feb 25, 2016May 12, 2016Aug 10, 2016Nov 10, 2016Feb 23, 2017May 11, 2017Aug 14, 2017Nov 10, 2017Feb 22, 2018May 14, 2018Aug 14, 2018Nov 14, 2018Feb 22, 2019May 14, 2019Aug 14, 2019Nov 14, 2019Feb 24, 2020May 14, 2020Aug 14, 2020Nov 12, 2020Feb 22, 2021May 13, 2021Aug 16, 2021Nov 15, 2021Feb 23, 2022May 13, 2022Aug 11, 2022Nov 14, 2022Feb 23, 2023May 12, 2023Aug 11, 2023Nov 13, 2023Feb 22, 2024May 14, 2024Aug 13, 2024Nov 11, 2024Feb 24, 2025May 16, 2025Aug 14, 2025Nov 13, 2025Feb 23, 2026May 13, 2026Aug 16, 2026
EPS Estimate--------0.150.210.100.210.20-0.160.310.260.380.250.370.330.510.280.330.300.470.360.280.370.510.390.390.510.610.520.620.640.560.610.650.630.610.600.670.630.730.560.740.720.660.600.56
EPS Actual0.210.230.070.150.130.290.120.190.180.310.130.250.190.340.220.340.280.440.300.330.290.470.290.250.330.440.370.350.390.490.380.540.630.540.720.620.760.460.530.850.710.880.570.771.010.550.520.450.570.690.650.54
Surprise--------20.00%47.62%30.00%19.05%-5.00%-37.50%9.68%7.69%15.79%20.00%-10.81%-12.12%-7.84%3.57%-24.24%10.00%-6.38%2.78%25.00%5.41%-3.92%-2.56%38.46%23.53%-11.48%38.46%0.00%18.75%-17.86%-13.11%30.77%12.70%44.26%-5.00%14.93%60.32%-24.66%-7.14%-39.19%-20.83%4.55%8.33%-3.57%
Timing----Pre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap29.43B
Enterprise Value28.07B
Trailing P/E13.45
Forward P/E13.09
PEG Ratio1.19
Price / Sales2.03
Price / Book3.03
EPS2.51
Book Value11.86
Revenue (TTM)14.53B
Gross Profit (TTM)7.64B
EBITDA3.23B
Profit Margin15.08%
Operating Margin17.02%
Return on Equity21.59%
Return on Assets12.66%
Shares Outstanding871.87M
Shares Float346.82M
Beta0.30
Dividend Yield5.04%
Dividend Rate1.70
Payout Ratio67.35%

Dividends

20262×
0.85Aug 26, 20260.80Mar 9, 2026
20252×
0.80Aug 27, 20250.80Mar 7, 2025
20242×
0.30Aug 23, 20240.25Mar 6, 2024
20232×
0.42Aug 24, 20230.58Mar 8, 2023
20222×
0.60Aug 24, 20220.56Mar 8, 2022
20212×
0.39Aug 27, 20210.21Mar 8, 2021
20202×
0.07Aug 27, 20200.14Mar 9, 2020
20192×
0.15Aug 28, 20190.25Mar 11, 2019
20182×
0.31Aug 28, 20180.40Mar 9, 2018
20172×
0.30Aug 25, 20170.24Mar 8, 2017
20162×
0.23Aug 23, 20160.24Mar 9, 2016
20152×
0.16Aug 26, 20150.15Mar 9, 2015